Mankind Pharma Limited

Overview

Mankind Pharma Limited is a leading pharmaceutical company based in India, dedicated to improving healthcare in the country and beyond. The company provides a wide range of high-quality and affordable medications spanning multiple therapeutic areas.

Therapeutic areas

API / Drug Master Files

Mankind Pharma Limited holds 32 active (32 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• PERFLUOROHEXYLOCTANEActive2026-03-27
• LIFITEGRASTActive2026-03-18
• EMPAGLIFLOZINActive2025-09-30
• EMPAGLIFLOZIN (PROCESS II)Active2025-02-27
• MIDODRINE HYDROCHLORIDE USPActive2024-11-18
• CILNIDIPINEActive2024-05-01
• ROCURONIUM BROMIDE USPActive2024-03-28
• CLOZAPINE USPActive2023-02-01
• SUCCINYLCHOLINE CHLORIDE USPActive2022-07-25
• VILDAGLIPTINActive2022-07-02
• BACLOFEN USPActive2022-04-27
• TELMISARTAN USPActive2022-03-23
• REVEFENACINActive2022-02-18
• TICAGRELORActive2022-02-01
• SACUBITRIL VALSARTAN TRISODIUM (AMORPHOUS)Active2022-01-17

Showing 15 of 32 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Mankind Pharma Limited in our records. PharmaTek screens the full directory against live FDA enforcement data.